Drugs and Supplements A-Z

Browse alphabetically Medicines Human :

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Orfan Drugs

Browse alphabetically Supplements:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Veterinary medicines:

Wiew all Veterinary medicines

Medical Dictionary

Browse alphabetically:

A B C D E F G H I J K L M N O P Q R S T U W V Y Z

Drugs Manufacturers

UK Canada Denmark Greece Poland Portugal France Japan Sweden Italy China Argentina USA Norway Germany Brazil Spain Czech Republic

Latest Medical News

» U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
-Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved INLYTA® (axitinib), a kinase inhibitor, for the treatment of patients with advanced renal cell carcinoma (RCC)
29 Jan 2012 | Read


» Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for standard review of bosutinib as a treatment option for adult patients with previously treated Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML).
29 Jan 2012 | Read


» FDA approves Inlyta to treat patients with a type of advanced kidney cancer
The U.S. Food and Drug Administration approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.
29 Jan 2012 | Read


» FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
The U.S. Food and Drug Administration (FDA) is informing the public that testing positive for anti-JC virus (JCV) antibodies has been identified as a risk factor for progressive multifocal leukoencephalopathy (PML).
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 27, 2012
New drugs approved. List of drugs approved by FDA to date January 27, 2012
29 Jan 2012 | Read


» FDA. New and Generic Drug Approvals - January 26, 2012
New drugs approved. List of drugs approved by FDA to date January 26, 2012
29 Jan 2012 | Read


   

Latest Health Articles

Latest Drugs

Wrist Injuries and Disorders
Valley Fever
Verruca ( Warts)
Von Hippel-Lindau Disease
Vitiligo
Vulvar Cancer
Vulvar Disorders
Wegener`s Granulomatosis
West Nile Virus
Ureteral Disorders
Urethral Disorders
Usher Syndrome
Uterine Diseases
Vaginal Cancer
Toxoplasmosis
Tracheal Disorders
Tremor (Disease)
Trichomoniasis
Tuberous Sclerosis
Turner Syndrome
Uncommon Infant and Newborn Problems
Underweight
Tendinitis
Testicular Cancer
Testicular Disorders
Thoracic Outlet Syndrome
Thymus Cancer
Thyroid Cancer
Trigeminal Neuralgia
Tinnitus
 Efavirenz Teva
Desloratadine Actavis
Repaglinide Accord
Emselex
Hepsera
Zulvac 1 Ovis
Zulvac 1 Bovis
Levetiracetam Sun
Inovelon
Olanzapine Glenmark Europe
Ameluz
Eltrombopag olamine
Ypozane
9-cis-Retinyl acetate
Cholic acid
Prepandrix
Nanoliposomal irinotecan
Human haptoglobin
Alpha-tocotrienol quinone
Sodium valproate
Dificlir
Komboglyze
Ipreziv
Edarbi
Clopidogrel Apotex
Dasselta
Levetiracetam Actavis Group
Edurant
Eviplera
Foscan

General Search

Last medical tags:


Torisel, temsirolimus, Inlyta, chronic myeloid leukemia, bosutinib, Inlyta, renal cell carcinoma, kidney cancer, myelin, Tysabri, natalizumab, brain infection, progressive multifocal leukoencephalopathy, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, thoracic aortic transection, endovascular graft, methotrexate, Voraxaze, cancer chemotherapy drug, glucarpidase, Adcetris, bleomycin, multifocal leukoencephalopathy, CardioGen-82, radiation, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, FDA, New drugs approval 2012, drugs approved by FDA, raltegravir, Isentress, antiretroviral medicines, Theravance, Relovair, asthma, fluticasone, bronchitis, neuromuscular disease, SMA, muscle atrophy, Resolor, prokinetic, prucalopride, ADHD, psychiatric behavioural disorder, Venvanse, lisdexamfetamine dimesylate, type 2 diabetes mellitus, Actoplus Met XR, pioglitazone, Mylan, Eprosartan Mesylate Tablets, Teveten, antimicrobials, cephapirin, cephalosporin, teriflunomide, Rebif, alanine aminotransferase levels, flu-like symptoms, multiple sclerosis, electrical pulses, implantable pulse generator, Precision Plus Spinal Cord Stimulator, genetic blood clotting disorder, hemophilia A, Advate, bleeding episodes, heart failure, heart transplantation, Pediatric Medical Device Safety, pulsatile cardiac assist device, selective serotonin reuptake inhibitor, SSRI, pulmonary hypertension,
» All tags  
Sitemap